Precision Medicine Startup ImpriMed Spearheads AI Breakthroughs in Canine Lymphoma Treatment at Veterinary Symposium – Draper Decentralized – 4.26.24
ImpriMed, a leading precision medicine startup made a significant contribution to the Symposium on Artificial Intelligence in Veterinary Medicine (SAVY) hosted by Cornell University. Dr. Sungwon Lim, CEO of ImpriMed, led a session on April 20th focusing on the application of AI in individualizing drug selection for canine lymphoma treatment.